Form 4 holding
Former 10% Owner
Theravance Biopharma, Inc.
- Security class
- Ordinary Shares
- Shares / value
- 0
- Estimated value
- Report date
- 16 Sep 2022
- Price
- $10.29
- Ownership
- By Corporation
GSK plc - Former 10% Owner at Theravance Biopharma, Inc.
Issuer-level insider activity
- Role
- Former 10% Owner
- Issuer ticker
- TBPH on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by GSK plc since 14 Oct 2025
Reported holdings for GSK plc in Theravance Biopharma, Inc.
Form 4 holding
Former 10% Owner
Theravance Biopharma, Inc.
- Security class
- Exchangeable Senior Notes due 2023
- Shares / value
- 0
- Estimated value
- Report date
- 16 Sep 2022
- Price
- Ownership
- Indirect
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for GSK plc in Theravance Biopharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.